Cargando…

Delay of EGF-Stimulated EGFR Degradation in Myotonic Dystrophy Type 1 (DM1)

Myotonic dystrophy type 1 (DM1) is an autosomal dominant disease caused by a CTG repeat expansion in the 3′ untranslated region of the dystrophia myotonica protein kinase gene. AKT dephosphorylation and autophagy are associated with DM1. Autophagy has been widely studied in DM1, although the endocyt...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alegre-Cortés, Eva, Giménez-Bejarano, Alberto, Uribe-Carretero, Elisabet, Paredes-Barquero, Marta, Marques, André R. A., Lopes-da-Silva, Mafalda, Vieira, Otília V., Canales-Cortés, Saray, Camello, Pedro J., Martínez-Chacón, Guadalupe, Aiastui, Ana, Fernández-Torrón, Roberto, López de Munain, Adolfo, Gomez-Suaga, Patricia, Niso-Santano, Mireia, González-Polo, Rosa A., Fuentes, José M., Yakhine-Diop, Sokhna M. S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9562898/ https://www.ncbi.nlm.nih.gov/pubmed/36230978 http://dx.doi.org/10.3390/cells11193018

Ejemplares similares

Toxicity of Necrostatin-1 in Parkinson’s Disease Models
por: Alegre-Cortés, Eva, et al.
Publicado: (2020)

Biological effects of olive oil phenolic compounds on mitochondria
por: Blanco-Benítez, Mercedes, et al.
Publicado: (2022)

Loss of KEAP1 Causes an Accumulation of Nondegradative Organelles
por: Uribe-Carretero, Elisabet, et al.
Publicado: (2022)

Mitochondrial Dysfunction in Repeat Expansion Diseases
por: Giménez-Bejarano, Alberto, et al.
Publicado: (2023)

Neuroprotective properties of queen bee acid by autophagy induction
por: Martínez-Chacón, Guadalupe, et al.
Publicado: (2021)

The paradigm of protein acetylation in Parkinson’s disease
por: Yakhine-Diop, Sokhna M.S., et al.
Publicado: (2019)

Acetylome in Human Fibroblasts From Parkinson's Disease Patients
por: Yakhine-Diop, Sokhna M. S., et al.
Publicado: (2018)

Changes in Liver Lipidomic Profile in G2019S-LRRK2 Mouse Model of Parkinson’s Disease
por: Corral Nieto, Yaiza, et al.
Publicado: (2023)

Muscle wasting in myotonic dystrophies: a model of premature aging
por: Mateos-Aierdi, Alba Judith, et al.
Publicado: (2015)

The dual role of necrostatin-1 in Parkinson’s disease models
por: Alegre-Cortés, Eva, et al.
Publicado: (2021)

Metabolic alterations in plasma from patients with familial and idiopathic Parkinson’s disease
por: Yakhine-Diop, Sokhna M.S., et al.
Publicado: (2020)

ER–mitochondria signaling in Parkinson’s disease
por: Gómez-Suaga, Patricia, et al.
Publicado: (2018)

Myotonic Dystrophy type 1 cells display impaired metabolism and mitochondrial dysfunction that are reversed by metformin
por: García-Puga, Mikel, et al.
Publicado: (2020)

Senescence plays a role in myotonic dystrophy type 1
por: García-Puga, Mikel, et al.
Publicado: (2022)

Reproductive Cancer Risk Factors in Women With Myotonic Dystrophy (DM): Survey Data From the US and UK DM Registries
por: Higgs, Cecilia, et al.
Publicado: (2019)

Regional brain atrophy in gray and white matter is associated with cognitive impairment in Myotonic Dystrophy type 1
por: Labayru, Garazi, et al.
Publicado: (2019)

Leukocyte telomere length in patients with myotonic dystrophy type I: a pilot study
por: Wang, Youjin, et al.
Publicado: (2019)

Targeting Myotonic Dystrophy Type 1 with Metformin
por: García-Puga, Mikel, et al.
Publicado: (2022)

Transcriptional signatures of synaptic vesicle genes define myotonic dystrophy type I neurodegeneration
por: Jimenez‐Marin, Antonio, et al.
Publicado: (2021)

Implication of Autophagy in Parkinson's Disease
por: González-Polo, Rosa Ana, et al.
Publicado: (2013)

Cognitive deficits and CTG repeat expansion size in classical myotonic dystrophy type 1 (DM1)
por: Winblad, Stefan, et al.
Publicado: (2006)

Development of an AP-FRET Based Analysis for Characterizing RNA-Protein Interactions in Myotonic Dystrophy (DM1)
por: Rehman, Shagufta, et al.
Publicado: (2014)

Targeting Toxic RNAs that Cause Myotonic Dystrophy Type 1 (DM1) with a Bisamidinium Inhibitor
por: Wong, Chun-Ho, et al.
Publicado: (2014)

Blood Transcriptome Profiling Links Immunity to Disease Severity in Myotonic Dystrophy Type 1 (DM1)
por: Nieuwenhuis, Sylvia, et al.
Publicado: (2022)

Intergenerational Influence of Gender and the DM1 Phenotype of the Transmitting Parent in Korean Myotonic Dystrophy Type 1
por: Han, Ji Yoon, et al.
Publicado: (2022)

Fluid Biomarkers of Central Nervous System (CNS) Involvement in Myotonic Dystrophy Type 1 (DM1)
por: Rossi, Salvatore, et al.
Publicado: (2023)

mRNA and protein dataset of autophagy markers (LC3 and p62) in several cell lines
por: Gómez-Sánchez, Rubén, et al.
Publicado: (2016)

Social cognition in myotonic dystrophy type 1: Specific or secondary impairment?
por: Labayru, Garazi, et al.
Publicado: (2018)

Oxidant–antioxidant imbalance in the serum of Myotonic Dystrophy type 1 (DM1) patients correlates with the progression of disease
por: Kumar, Ashok, et al.
Publicado: (2014)

Manumycin A corrects aberrant splicing of Clcn1 in myotonic dystrophy type 1 (DM1) mice
por: Oana, Kosuke, et al.
Publicado: (2013)

Vorinostat Improves Myotonic Dystrophy Type 1 Splicing Abnormalities in DM1 Muscle Cell Lines and Skeletal Muscle from a DM1 Mouse Model
por: Neault, Nafisa, et al.
Publicado: (2023)

White matter integrity changes and neurocognitive functioning in adult-late onset DM1: a follow-up DTI study
por: Labayru, Garazi, et al.
Publicado: (2022)

Neurodegeneration trajectory in pediatric and adult/late DM1: A follow‐up MRI study across a decade
por: Labayru, Garazi, et al.
Publicado: (2020)

DJ-1 as a Modulator of Autophagy: An Hypothesis
por: González-Polo, Rosa A., et al.
Publicado: (2010)

Comparisons of intellectual capacities between mild and classic adult-onset phenotypes of myotonic dystrophy type 1 (DM1)
por: Jean, Stéphane, et al.
Publicado: (2014)

(CCUG)(n) RNA toxicity in a Drosophila model of myotonic dystrophy type 2 (DM2) activates apoptosis
por: Yenigun, Vildan Betul, et al.
Publicado: (2017)

Age of Onset of RNA Toxicity Influences Phenotypic Severity: Evidence from an Inducible Mouse Model of Myotonic Dystrophy (DM1)
por: Gladman, Jordan T., et al.
Publicado: (2013)

Predictors of prognosis in type 1 myotonic dystrophy (DM1): longitudinal 18-years experience from a single center
por: Mazzoli, Marco, et al.
Publicado: (2020)

Muscle magnetic resonance imaging in myotonic dystrophy type 1 (DM1): Refining muscle involvement and implications for clinical trials
por: Garibaldi, Matteo, et al.
Publicado: (2021)

Age‐related cognitive decline in myotonic dystrophy type 1: An 11‐year longitudinal follow‐up study
por: Labayru, Garazi, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_h69dboss2d4e24p8qodi23c9tr